Value Investor
Start free

InspireMD

NSPR on Nasdaq. Market value $27m.

Watch this stockFree. We tell you when something changes.

Should I look at this?

Look carefully before going further

Why it could be worth it

Nothing stands out yet.

What to watch out for

Read the warning sign in its own filings

This is not advice.

Compare with another stock

Who owns it

None of the long-term investors we follow own it. 37 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

10 investors own more than 5%.

  • at least 10.0%0.0 pts
    (filed with 2 related holders)
    Since 31 March 2026
  • MARSHALL WACE, LLP
    Passive investor
    10.0%
    Since 30 September 2025
  • Rosalind Advisors, Inc.
    Passive investor
    at least 9.2%−0.7 pts
    (filed with 4 related holders)
    Since 31 December 2025
  • Michael A. Lawless
    Insider or founder
    8.6%
    Since 26 June 2025
    What they said

    Item 3 above is hereby incorporated into this Item 4 by reference. The Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the…

    Read the filing
  • Aberdeen Group plc
    Passive investor
    at least 7.5%+1.5 pts
    (filed with 1 related holder)
    Since 31 December 2025
  • ORBIMED ADVISORS LLC
    Passive investor
    at least 7.4%+3.3 pts
    (filed with 1 related holder)
    Since 31 December 2025
  • at least 5.8%
    (filed with 3 related holders)
    Since 30 September 2025
  • NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
    Passive investor
    5.7%
    Since 30 September 2025
  • Marvin Slosman
    Insider or founder
    5.2%
    Since 22 January 2026
    What they said

    Item 3 above is hereby incorporated into this Item 4 by reference. The Reporting Person serves as an executive officer of the Issuer and, in such capacity, may be involved in reviewing transactions involving the Issuer and may have influence over the corporate activities of the…

    Read the filing
  • at least 5.0%−0.1 pts
    (filed with 5 related holders)
    Since 31 March 2026
  • Craig Shore
    Insider or founder
    Sold down below 5%
    Since 26 June 2025
    What they said

    Item 3 above is hereby incorporated into this Item 4 by reference. As of the date hereof, the Reporting Person in his individual capacity does not have any present plans or proposals that relate to, or would result in, any actions or events specified in clauses (a) through (j)…

    Read the filing

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 4 insiders bought $420,887 of shares on the open market. 1 sold $126,870.

  • Stuka Paul
    Director
    Bought
    Date
    27 May 2026
    Shares
    20,000
    Price
    $0.88
    Value
    $17,600
  • Gleason Shane Thomas
    Chief Commercial Officer
    Sold
    Date
    19 May 2026
    Shares
    22,778
    Price
    $1.01
    Value
    $23,006
  • Stuka Paul
    Director
    Bought
    Date
    14 May 2026
    Shares
    5,000
    Price
    $1.15
    Value
    $5,750
  • Stuka Paul
    Director
    Bought
    Date
    13 May 2026
    Shares
    10,000
    Price
    $1.16
    Value
    $11,600
  • Slosman Marvin
    CEO and President, Director
    Bought
    Date
    12 May 2026
    Shares
    21,000
    Price
    $1.20
    Value
    $25,200
  • Stuka Paul
    Director
    Bought
    Date
    11 May 2026
    Shares
    10,000
    Price
    $1.19
    Value
    $11,900
  • Stuka Paul
    Director
    Bought
    Date
    8 May 2026
    Shares
    65,626
    Price
    $1.16
    Value
    $76,126
  • Ward Scott R.
    Director
    Bought
    Date
    7 May 2026
    Shares
    73,255
    Price
    $1.15
    Value
    $84,243
  • Stuka Paul
    Director
    Bought
    Date
    7 May 2026
    Shares
    6,378
    Price
    $1.15
    Value
    $7,335
  • ROUBIN GARY S
    Director
    Bought
    Date
    7 May 2026
    Shares
    90,000
    Price
    $1.18
    Value
    $106,200

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

1 serious warning sign in InspireMD’s filings.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 18 Mar 2026, plus the 10-Q filed 14 Aug 2026 and 11 later 8-Ks.

  • Doubt it can keep going

    Serious

    The company or its auditor warned it may not have enough money to last the next year.

    “Therefore, there is substantial doubt about the Company’s ability to continue as a going concern.”
    Show the full paragraph
    The Company has an accumulated deficit as of June 30, 2026, as well as a history of net losses and negative operating cash flows. The Company expects to continue incurring losses and negative cash flows from operations until the Company expands its commercial revenue to a scale that funds its commercial resources, development activities and support functions. As a result of these expected losses and negative cash flows from operations, along with the Company’s current cash position, the Company does not have sufficient resources to fund operations for at least the next 12 months. Therefore, there is substantial doubt about the Company’s ability to continue as a going concern. These financial statements have been prepared assuming that the Company will continue as a going concern and do not include any adjustments that might result from the outcome of this uncertainty.

    From the 10-Q filed 14 August 2026, Part I, Item 1. Financial Statements. Read it in the filing

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from
Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.